CIMZIA(R) (certolizumab Pegol) Reduces Intestinal Lesions And Induces Endoscopic Improvement In Crohn’s Patients
Oct 13th 2008Drug InformationCrohn
UCB presented data from a large, prospective study investigating endoscopic improvement in Crohn’s disease (CD) with a biologic compound.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
